Lee, H.E.; Park, S.-B.; Kim, H.-Y.; Baik, S.H.; Jung, K.; Kim, J.; Park, J.Y.
Safety and Influenza Infections in Children Aged 6–35 Months Receiving Cell Culture-Derived Inactivated Quadrivalent Influenza Vaccine During the 2023–2024 Influenza Season in South Korea. Vaccines 2025, 13, 501.
https://doi.org/10.3390/vaccines13050501
AMA Style
Lee HE, Park S-B, Kim H-Y, Baik SH, Jung K, Kim J, Park JY.
Safety and Influenza Infections in Children Aged 6–35 Months Receiving Cell Culture-Derived Inactivated Quadrivalent Influenza Vaccine During the 2023–2024 Influenza Season in South Korea. Vaccines. 2025; 13(5):501.
https://doi.org/10.3390/vaccines13050501
Chicago/Turabian Style
Lee, Hye Eun, Seong-Beom Park, Hye-Young Kim, Sun Heom Baik, Kyungyeon Jung, Juhwan Kim, and Ji Young Park.
2025. "Safety and Influenza Infections in Children Aged 6–35 Months Receiving Cell Culture-Derived Inactivated Quadrivalent Influenza Vaccine During the 2023–2024 Influenza Season in South Korea" Vaccines 13, no. 5: 501.
https://doi.org/10.3390/vaccines13050501
APA Style
Lee, H. E., Park, S.-B., Kim, H.-Y., Baik, S. H., Jung, K., Kim, J., & Park, J. Y.
(2025). Safety and Influenza Infections in Children Aged 6–35 Months Receiving Cell Culture-Derived Inactivated Quadrivalent Influenza Vaccine During the 2023–2024 Influenza Season in South Korea. Vaccines, 13(5), 501.
https://doi.org/10.3390/vaccines13050501
